|
|
|
Insider
Information: |
Smither John W |
Relationship: |
Director |
City: |
Calabasas |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
89,084 |
|
Indirect Shares
|
176,353 |
|
|
Direct
Value |
$122,234 |
|
|
Indirect Value
|
$1,295,151 |
|
|
Total
Shares |
265,437 |
|
|
Total
Value |
$1,417,385 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
1
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
1
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
Percentage
Gain/Loss : |
0.0%
|
-78.3%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Kythera Biopharmaceuticals Inc |
KYTH |
Chief Financial Officer |
2015-10-01 |
0 |
2015-10-01 |
0 |
Premium* |
|
Sienna Biopharmaceuticals, Inc. |
SNNA |
|
2019-01-01 |
46,657 |
2019-01-01 |
34,961 |
Premium* |
|
Arcutis Biotherapeutics, Inc. |
ARQT |
Chief Financial Officer |
2024-02-13 |
11,365 |
2024-02-13 |
141,392 |
Premium* |
|
Effector Therapeutics Ord Shs |
EFTR |
Director |
2021-08-25 |
24,142 |
2021-08-25 |
0 |
Premium* |
|
Genelux Corp |
GNLX |
Director |
2023-09-13 |
6,920 |
2023-09-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 1
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
SNNA |
Sienna Biopharmaceuticals... |
Chief Financial Officer |
|
2019-01-01 |
4 |
A |
$0.00 |
$0 |
D/D |
45,000 |
46,657 |
0 |
- |
|
KYTH |
Kythera Biopharmaceutical... |
Chief Financial Officer |
|
2013-09-10 |
4 |
OE |
$1.35 |
$40,500 |
D/D |
30,000 |
30,000 |
0 |
- |
|
KYTH |
Kythera Biopharmaceutical... |
Chief Financial Officer |
|
2013-09-10 |
4 |
AS |
$30.03 |
$900,996 |
D/D |
(30,000) |
0 |
0 |
- |
|
KYTH |
Kythera Biopharmaceutical... |
Chief Financial Officer |
|
2015-09-23 |
4 |
OE |
$8.22 |
$484,361 |
D/D |
26,918 |
17,014 |
0 |
- |
|
KYTH |
Kythera Biopharmaceutical... |
Chief Financial Officer |
|
2015-09-23 |
4 |
S |
$74.90 |
$2,016,158 |
D/D |
(26,918) |
3,368 |
0 |
- |
|
KYTH |
Kythera Biopharmaceutical... |
Chief Financial Officer |
|
2015-09-24 |
4 |
S |
$74.90 |
$2,016,083 |
D/D |
(26,917) |
3,368 |
0 |
- |
|
KYTH |
Kythera Biopharmaceutical... |
Chief Financial Officer |
|
2015-09-24 |
4 |
OE |
$27.50 |
$967,582 |
D/D |
26,917 |
17,131 |
0 |
- |
|
EFTR |
Effector Therapeutics Ord... |
Director |
|
2021-08-25 |
4 |
A |
$0.00 |
$0 |
D/D |
24,142 |
24,142 |
0 |
- |
|
KYTH |
Kythera Biopharmaceutical... |
Chief Financial Officer |
|
2015-10-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(17,960) |
0 |
0 |
- |
|
KYTH |
Kythera Biopharmaceutical... |
Chief Financial Officer |
|
2014-09-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
16,200 |
6,216 |
0 |
- |
|
ARQT |
Arcutis Biotherapeutics, ... |
Chief Financial Officer |
|
2020-06-11 |
4 |
OE |
$1.68 |
$24,999 |
D/D |
14,875 |
123,840 |
0 |
- |
|
KYTH |
Kythera Biopharmaceutical... |
Chief Financial Officer |
|
2015-09-25 |
4 |
OE |
$4.84 |
$67,842 |
D/D |
14,017 |
17,385 |
0 |
- |
|
ARQT |
Arcutis Biotherapeutics, ... |
Chief Financial Officer |
|
2021-03-04 |
4 |
OE |
$1.68 |
$20,833 |
D/D |
12,396 |
46,321 |
0 |
- |
|
ARQT |
Arcutis Biotherapeutics, ... |
Chief Financial Officer |
|
2024-02-13 |
4 |
A |
$0.00 |
$0 |
D/D |
11,365 |
11,365 |
0 |
- |
|
KYTH |
Kythera Biopharmaceutical... |
Chief Financial Officer |
|
2013-08-01 |
4 |
OE |
$1.35 |
$13,500 |
D/D |
10,000 |
10,000 |
0 |
- |
|
KYTH |
Kythera Biopharmaceutical... |
Chief Financial Officer |
|
2013-08-01 |
4 |
AS |
$26.80 |
$268,005 |
D/D |
(10,000) |
0 |
0 |
- |
|
KYTH |
Kythera Biopharmaceutical... |
Chief Financial Officer |
|
2013-09-09 |
4 |
OE |
$1.35 |
$13,500 |
D/D |
10,000 |
10,000 |
0 |
- |
|
KYTH |
Kythera Biopharmaceutical... |
Chief Financial Officer |
|
2013-09-09 |
4 |
AS |
$30.00 |
$300,000 |
D/D |
(10,000) |
0 |
0 |
- |
|
ARQT |
Arcutis Biotherapeutics, ... |
Chief Financial Officer |
|
2021-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
9,500 |
33,925 |
0 |
- |
|
KYTH |
Kythera Biopharmaceutical... |
Chief Financial Officer |
|
2013-11-06 |
4 |
OE |
$1.35 |
$12,150 |
D/D |
9,000 |
9,000 |
0 |
- |
|
ARQT |
Arcutis Biotherapeutics, ... |
Chief Financial Officer |
|
2020-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
9,000 |
108,965 |
0 |
- |
|
GNLX |
Genelux Corp |
Director |
|
2023-09-11 |
4 |
A |
$0.00 |
$0 |
D/D |
6,920 |
7,820 |
0 |
- |
|
KYTH |
Kythera Biopharmaceutical... |
Chief Financial Officer |
|
2015-01-05 |
4 |
OE |
$1.35 |
$8,392 |
D/D |
6,216 |
22,416 |
0 |
- |
|
KYTH |
Kythera Biopharmaceutical... |
Chief Financial Officer |
|
2015-01-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
6,216 |
0 |
0 |
- |
|
KYTH |
Kythera Biopharmaceutical... |
Chief Financial Officer |
|
2015-10-01 |
4 |
D |
$0.00 |
$0 |
I/I |
(6,216) |
0 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|